title: Synthetic liposomes are protective from bleomycin-induced lung toxicity.
abstract: Idiopathic pulmonary fibrosis is a devastating disease characterized by a progressive, irreversible, and ultimately lethal form of lung fibrosis. Except for lung transplantation, no effective treatment options currently exist. The bleomycin animal model is one of the best studied models of lung injury and fibrosis. A previous study using mouse tumor models observed that liposome-encapsulated bleomycin exhibited reduced lung toxicity. Therefore, we hypothesized that airway delivery of synthetic phosphatidylcholine-containing liposomes alone would protect mice from bleomycin-induced lung toxicity. C57BL/6 mice were administered uncharged multilamellar liposomes (100 μl) or PBS vehicle on day 0 by airway delivery. Bleomycin (3.33 U/kg) or saline vehicle was then given intratracheally on day 1 followed by four additional separate doses of liposomes on days 4, 8, 12, and 16. Fluorescent images of liposomes labeled with 1,1'-dioctadecyl-3,3,3',3' tetramethylindocarbocyanine perchlorate confirmed effective and widespread delivery of liposomes to the lower respiratory tract as well as uptake primarily by alveolar macrophages and to a lesser extent by type II alveolar epithelial cells. Results at day 22, 3 wk after bleomycin treatment, showed that airway delivery of liposomes before and after intratracheal administration of bleomycin significantly reduced bleomycin-induced lung toxicity as evidenced by less body weight loss, chronic lung inflammation, and fibrosis as well as improved lung compliance compared with controls. These data indicate that airway-delivered synthetic liposomes represent a novel treatment strategy to reduce the lung toxicity associated with bleomycin in a mouse model.
authors: Laboratory of Respiratory Biology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.
authors: William M
authors: WM
authors: Gwinn
authors: Mayanga C
authors: MC
authors: Kapita
authors: Ping M
authors: PM
authors: Wang
authors: Mark F
authors: MF
authors: Cesta
authors: William J
authors: WJ
authors: Martin
references: Adv Exp Med Biol. 2007;620:117-28
references: 18217339
references: Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):1002-5
references: 8887598
references: J Appl Physiol (1985). 1991 Mar;70(3):1300-8
references: 1709634
references: Bull Exp Biol Med. 2006 Jun;141(6):682-4
references: 17364048
references: J Clin Invest. 1991 Dec;88(6):1976-81
references: 1752956
references: Am J Physiol Lung Cell Mol Physiol. 2002 Nov;283(5):L1079-85
references: 12376361
references: Drug Deliv. 2001 Jan-Mar;8(1):1-7
references: 11280437
references: J Appl Physiol (1985). 1989 Apr;66(4):1846-51
references: 2732176
references: Exp Lung Res. 1991 Jul-Aug;17(4):687-705
references: 1657589
references: Am J Physiol Lung Cell Mol Physiol. 2010 Mar;298(3):L348-60
references: 20034962
references: Toxicol Appl Pharmacol. 2004 Mar 1;195(2):218-31
references: 14998687
references: Curr Drug Saf. 2006 May;1(2):159-68
references: 18690927
references: Clin Exp Immunol. 1986 Feb;63(2):261-70
references: 3516464
references: J Immunoassay Immunochem. 2006;27(1):31-44
references: 16450867
references: Am J Respir Crit Care Med. 1998 Dec;158(6):1890-9
references: 9847283
references: Respir Care. 2009 Sep;54(9):1203-8
references: 19712497
references: Immunology. 1992 May;76(1):60-4
references: 1628902
references: Am J Physiol Lung Cell Mol Physiol. 2001 Dec;281(6):L1327-34
references: 11704526
references: Analyst. 1969 Jul;94(120):575-84
references: 5804368
references: J Cell Mol Med. 2002 Oct-Dec;6(4):465-74
references: 12611636
references: Exp Lung Res. 1992 Mar-Apr;18(2):191-204
references: 1572329
references: J Immunol. 2002 Oct 15;169(8):4504-10
references: 12370387
references: Int J Biochem Cell Biol. 2008;40(3):362-82
references: 17936056
references: Adv Exp Med Biol. 2009;653:74-97
references: 19799113
references: Am Rev Respir Dis. 1987 Sep;136(3):651-6
references: 3307569
references: Nihon Kyobu Shikkan Gakkai Zasshi. 1997 Nov;35(11):1163-72
references: 9493441
references: N Engl J Med. 1996 May 30;334(22):1417-21
references: 8618579
references: Respir Physiol Neurobiol. 2008 Nov 30;163(1-3):244-55
references: 18632313
references: Eur Respir J. 1999 Sep;14(3):565-73
references: 10543276
references: Respir Res. 2001;2(6):353-64
references: 11737935
references: Am J Physiol Lung Cell Mol Physiol. 2008 Feb;294(2):L152-60
references: 17993587
references: Am Rev Respir Dis. 1987 Jul;136(1):113-8
references: 2440355
references: Am J Respir Med. 2002;1(6):417-33
references: 14720029
references: Am J Physiol. 1992 Apr;262(4 Pt 1):L367-85
references: 1566854
references: Bull Exp Biol Med. 2001 Feb;131(2):191-4
references: 11391410
references: Biull Eksp Biol Med. 1998 Oct;126(10):455-8
references: 9825150
references: Eur Respir J. 1998 Sep;12(3):533-9
references: 9762775
references: JAMA. 1994 Nov 9;272(18):1433-8
references: 7933425
references: Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):834-6
references: 8214936
references: Proc Am Thorac Soc. 2007 Jul;4(3):252-7
references: 17607008
references: Am J Physiol Lung Cell Mol Physiol. 2001 Apr;280(4):L689-94
references: 11238009
references: J Appl Physiol (1985). 1991 Oct;71(4):1270-6
references: 1757348
references: Eur Respir J. 1998 Aug;12(2):284-7
references: 9727775